Assessment of established techniques to determine developmental and malignant potential of human pluripotent stem cells

[1]  The Initiative.  Assessment of established techniques to determine developmental and malignant potential of human pluripotent stem cells , 2018 .

[2]  C. Mummery,et al.  Differentiation-Defective Human Induced Pluripotent Stem Cells Reveal Strengths and Limitations of the Teratoma Assay and In Vitro Pluripotency Assays , 2017, Stem cell reports.

[3]  P. Andrews,et al.  Teratomas produced from human pluripotent stem cells xenografted into immunodeficient mice - a histopathology atlas. , 2016, The International journal of developmental biology.

[4]  Miguel A. Juárez,et al.  Detecting Genetic Mosaicism in Cultures of Human Pluripotent Stem Cells , 2016, Stem cell reports.

[5]  R. Pedersen,et al.  Contributions of Mammalian Chimeras to Pluripotent Stem Cell Research , 2016, Cell stem cell.

[6]  N. Benvenisty,et al.  Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq , 2016, Nature Communications.

[7]  P. Unger,et al.  ZBTB16: a novel sensitive and specific biomarker for yolk sac tumor , 2016, Modern Pathology.

[8]  G. Sauter,et al.  The zinc-finger transcription factor SALL4 is frequently expressed in human cancers: association with clinical outcome in squamous cell carcinoma but not in adenocarcinoma of the esophagus , 2016, Virchows Archiv.

[9]  N. Benvenisty,et al.  TeratoScore: Assessing the Differentiation Potential of Human Pluripotent Stem Cells by Quantitative Expression Analysis of Teratomas , 2015, Stem cell reports.

[10]  G. Kempermann.  Faculty Opinions recommendation of Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. , 2015 .

[11]  Jun S. Liu,et al.  The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans , 2015, Science.

[12]  Genomic instability of human embryonic stem cell lines using different passaging culture methods , 2015, Molecular Cytogenetics.

[13]  C. Mummery,et al.  Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI). , 2015, Regenerative medicine.

[14]  Suzanne S Farid,et al.  Human pluripotent stem cell-derived products: Advances towards robust, scalable and cost-effective manufacturing strategies , 2014, Biotechnology journal.

[15]  A. Meissner,et al.  A qPCR ScoreCard quantifies the differentiation potential of human pluripotent stem cells , 2015 .

[16]  N. Benvenisty,et al.  Aneuploidy induces profound changes in gene expression, proliferation and tumorigenicity of human pluripotent stem cells , 2014, Nature Communications.

[17]  V. Tabar,et al.  Pluripotent stem cells in regenerative medicine: challenges and recent progress , 2014, Nature Reviews Genetics.

[18]  T. Ichisaka,et al.  Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells , 2013, Proceedings of the National Academy of Sciences.

[19]  R. Lothe,et al.  BCL-XL Mediates the Strong Selective Advantage of a 20q11.21 Amplification Commonly Found in Human Embryonic Stem Cell Cultures , 2013, Stem cell reports.

[20]  O. Gordeeva,et al.  Development of Experimental Tumors Formed by Mouse and Human Embryonic Stem and Teratocarcinoma Cells after Subcutaneous and Intraperitoneal Transplantations into Immunodeficient and Immunocompetent Mice , 2013, Cell transplantation.

[21]  Andrew McDavid,et al.  Data exploration, quality control and testing in single-cell qPCR-based gene expression experiments , 2012, Bioinform..

[22]  Cole Trapnell,et al.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.

[23]  L. Looijenga,et al.  Lessons from human teratomas to guide development of safe stem cell therapies , 2012, Nature Biotechnology.

[24]  Dong Ryul Lee,et al.  Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage , 2011, Nature Biotechnology.

[25]  Hana Kim,et al.  Rex1/Zfp42 as an epigenetic regulator for genomic imprinting. , 2011, Human molecular genetics.

[26]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[27]  Bernhard M. Schuldt,et al.  A bioinformatic assay for pluripotency in human cells , 2011, Nature Methods.

[28]  Michael J. Ziller,et al.  Reference Maps of Human ES and iPS Cell Variation Enable High-Throughput Characterization of Pluripotent Cell Lines , 2011, Cell.

[29]  Yoav Mayshar,et al.  Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. , 2010, Cell stem cell.

[30]  Thierry Rème,et al.  Amazonia!: An Online Resource to Google and Visualize Public Human whole Genome Expression Data , 2010 .

[31]  N. Benvenisty,et al.  The tumorigenicity of diploid and aneuploid human pluripotent stem cells , 2009, Cell cycle.

[32]  Heidi Dvinge,et al.  HTqPCR: high-throughput analysis and visualization of quantitative real-time PCR data in R , 2009, Bioinform..

[33]  D. Rakheja,et al.  Diagnostic Utility of SALL4 in Extragonadal Yolk Sac Tumors: An Immunohistochemical Study of 59 Cases With Comparison to Placental-like Alkaline Phosphatase, Alpha-fetoprotein, and Glypican-3 , 2009, The American journal of surgical pathology.

[34]  V. Reuter,et al.  Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2 and GDF3, with emphasis on morphologically difficult-to-classify areas , 2009, Modern Pathology.

[35]  S. Reuveny,et al.  Long-term microcarrier suspension cultures of human embryonic stem cells. , 2009, Stem cell research.

[36]  A. Schnerch,et al.  Characterization of human embryonic stem cells with features of neoplastic progression , 2009, Nature Biotechnology.

[37]  P. Robson,et al.  Sall4 regulates distinct transcription circuitries in different blastocyst-derived stem cell lineages. , 2008, Cell stem cell.

[38]  G. Lin,et al.  Tumor progression of culture‐adapted human embryonic stem cells during long‐term culture , 2008, Genes, chromosomes & cancer.

[39]  Seon-Young Kim,et al.  Gene-set approach for expression pattern analysis , 2008, Briefings Bioinform..

[40]  E. Stanley,et al.  A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies , 2008, Nature Protocols.

[41]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[42]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[43]  G. Churchill,et al.  Characterization of human embryonic stem cell lines by the International Stem Cell Initiative , 2007, Nature Biotechnology.

[44]  P. Andrews,et al.  Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin. , 2005, Biochemical Society transactions.

[45]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Richard P Davis,et al.  Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation. , 2005, Blood.

[47]  L. Looijenga,et al.  Testicular germ-cell tumours in a broader perspective , 2005, Nature Reviews Cancer.

[48]  Gordon K Smyth,et al.  Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .

[49]  J. Thomson,et al.  Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells , 2004, Nature Biotechnology.

[50]  D. Melton,et al.  Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[51]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[52]  C. Stolar,et al.  Immature teratomas in children: pathologic considerations: a report from the combined Pediatric Oncology Group/Children's Cancer Group. , 1998, The American journal of surgical pathology.

[53]  D. O'connor,et al.  The influence of grade on the outcome of stage I ovarian immature (malignant) teratomas and the reproducibility of grading. , 1994, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[54]  G. Martin,et al.  Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[55]  M. Kaufman,et al.  Establishment in culture of pluripotential cells from mouse embryos , 1981, Nature.

[56]  F. Gonzalez-crussi,et al.  Sacrococcygeal teratomas in infants and children: relationship of histology and prognosis in 40 cases. , 1978, Archives of pathology & laboratory medicine.

[57]  R. Brinster.  THE EFFECT OF CELLS TRANSFERRED INTO THE MOUSE BLASTOCYST ON SUBSEQUENT DEVELOPMENT , 1974, The Journal of experimental medicine.

[58]  I. Damjanov,et al.  Experimental teratoma. , 1974, Current topics in pathology. Ergebnisse der Pathologie.

[59]  D. Solter,et al.  Extrauterine Growth of Mouse Egg-cylinders results in Malignant Teratoma , 1970, Nature.

[60]  L. C. Stevens.  The development of transplantable teratocarcinomas from intratesticular grafts of pre- and postimplantation mouse embryos. , 1970, Developmental biology.

[61]  L. C. Stevens.  Origin of testicular teratomas from primordial germ cells in mice. , 1967, Journal of the National Cancer Institute.

[62]  L. C. Stevens.  The biology of teratomas. , 1967, Advances in morphogenesis.

[63]  G. B. Pierce,et al.  MULTIPOTENTIALITY OF SINGLE EMBRYONAL CARCINOMA CELLS. , 1964, Cancer research.

[64]  L. C. Stevens,et al.  Spontaneous Testicular Teratomas in an Inbred Strain of Mice. , 1954, Proceedings of the National Academy of Sciences of the United States of America.

[65]  Robert A. Moore,et al.  Tumors of the testis. , 1946, The Journal of the Kansas Medical Society.

[66]  N. Friedman,et al.  Tumors of the testis; a report on 922 cases. , 1947, Military surgeon.

[67]  Moore Ra,et al.  Tumors of the testis; a report on 922 cases. , 1946 .